However, prognostic studies have indicated that PAI-1 is also a clinical marker for a poor prognosis in a variety of human cancers, suggesting that it plays an important role in promoting tumour progression and invasion (Grondahl-Hansen et al, 1993; Cho et al, 1997; Knoop et al, 1998). Here, SERPINE1 is linked to neoplasm.